Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

This publication has 173 references indexed in Scilit:

• Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
  Proceedings of the National Academy of Sciences, 2009
• Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosis
  Tuberculosis, 2009
• Averting epidemics of extensively drug-resistant tuberculosis
  Proceedings of the National Academy of Sciences, 2009
• Drivers of tuberculosis epidemics: The role of risk factors and social determinants
  Social Science & Medicine, 2009
• Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
  The Lancet, 2009
• Development and Validation of a Protein-based Signature for the Detection of Ovarian Cancer
  Clinics In Laboratory Medicine, 2009
• Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing
  Proceedings of the National Academy of Sciences, 2008
• Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
  Nature Medicine, 2007
• Reducing the global burden of tuberculosis: the contribution of improved diagnostics
  Nature, 2006
• Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
  Clinical Pharmacology & Therapeutics, 2001